Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/31224
Title: | Choosing Estimands in Clinical Trials: Putting the ICH E9(R1) Into Practice | Authors: | Ratitch, Bohdana Bell, James Mallinckrodt, Craig Bartlett, Jonathan W. Goel, Niti MOLENBERGHS, Geert O'Kelly, Michael Singh, Pritibha Lipkovich, Ilya |
Issue Date: | 2020 | Publisher: | SPRINGER HEIDELBERG | Source: | THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 54 (2) , p. 324 -341 | Abstract: | The National Research Council (NRC) Expert Panel Report on Prevention and Treatment of Missing Data in Clinical Trials highlighted the need for clearly defining objectives and estimands. That report sparked considerable discussion and literature on estimands and how to choose them. Importantly, consideration moved beyond missing data to include all postrandomization events that have implications for estimating quantities of interest (intercurrent events, aka ICEs). The ICH E9(R1) draft addendum builds on that research to outline key principles in choosing estimands for clinical trials, primarily with focus on confirmatory trials. This paper provides additional insights, perspectives, details, and examples to help put ICH E9(R1) into practice. Specific areas of focus include how the perspectives of different stakeholders influence the choice of estimands; the role of randomization and the intention-to-treat principle; defining the causal effects of a clearly defined treatment regimen, along with the implications this has for trial design and the generalizability of conclusions; detailed discussion of strategies for handling ICEs along with their implications and assumptions; estimands for safety objectives, time-to-event endpoints, early-phase and one-arm trials, and quality of life endpoints; and realistic examples of the thought process involved in defining estimands in specific clinical contexts. | Notes: | O'Kelly, M (reprint author), IQVIA, Estuary House,East Point Business Pk, Dublin 3, Ireland. Michael.OKelly@iqvia.com |
Other: | O'Kelly, M (reprint author), IQVIA, Estuary House,East Point Business Pk, Dublin 3, Ireland. Michael.OKelly@iqvia.com | Keywords: | estimands;clinical trials;intercurrent events | Document URI: | http://hdl.handle.net/1942/31224 | ISSN: | 2168-4790 | e-ISSN: | 2168-4804 | DOI: | 10.1007/s43441-019-00061-x | ISI #: | WOS:000522455300010 | Rights: | 2020 Springer Nature Switzerland AG. Part of Springer Nature. | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2021 |
Appears in Collections: | Research publications |
Show full item record
SCOPUSTM
Citations
2
checked on Sep 7, 2020
WEB OF SCIENCETM
Citations
40
checked on Sep 28, 2024
Page view(s)
40
checked on May 30, 2023
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.